Across CCLE and GDSC cell-line panels, response to AZ6102 is significantly associated with the shRNA pathway dependency of multiple pathways, with PANCREAS cell lines showing a particularly strong set of associations.
The most reproducible AZ6102 response-associated pathways across cancer lineages are Regulation of NMDA receptor activity, Negative regulation of dendritic spine maintenance, and Regulation of transepithelial transport, each associated with drug response in up to 8 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, AZ6102 response versus Regulation of NMDA receptor activity shRNA pathway dependency in PANCREAS (Pearson r = 0.77).